Tevogen Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on August 24, 2026, regarding Tevogen Inc.'s Annual Meeting of Stockholders. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Warren, New Jersey. Its common stock (TVGN) and warrants (TVGNW) trade on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder actions. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the Company's most recent Form 10-K or 10-Q for financial statements.
Material Changes and Corporate Actions
The filing details the following material actions approved by stockholders at the Annual Meeting:
- Director Elections: Stockholders elected Dr. Keow Lin Goh and Victor Sordillo as Class II directors for three-year terms.
- Accounting Firm Ratification: Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Compensation Plan Amendment: Stockholders approved an amendment to the 2024 Omnibus Incentive Plan to increase the number of shares available for issuance by 100,000,000.
- Charter Amendment: Stockholders approved an amendment to the Certificate of Incorporation to permit stockholders to act by written consent in lieu of a meeting. This amendment was filed with the Delaware Secretary of State on August 26, 2026.
Voting Results
As of the record date (July 23, 2026), there were 6,416,540 shares outstanding. A quorum was established with 5,956,141 shares represented. Final voting results were:
| Proposal | Votes For | Votes Against | Abstentions | Broker Non-Votes |
|---|---|---|---|---|
| Election of Directors (Dr. Goh) | 5,397,703 | 22,265 | 2,653 | 533,520 |
| Election of Directors (V. Sordillo) | 5,395,249 | 24,751 | 2,621 | 533,520 |
| Ratification of KPMG LLP | 5,939,035 | 14,666 | 2,440 | 0 |
| 2024 Plan Amendment | 5,322,668 | 98,744 | 1,209 | 533,520 |
| Charter Amendment (Written Consent) | 5,382,051 | 38,005 | 2,565 | 533,520 |
Guidance, Outlook, and Risks
This filing contains no management guidance, financial outlook, or discussion of specific risks and contingencies. The primary focus is the execution of shareholder votes and the resulting corporate governance changes.
Key Facts for Investor Verification
- Verify the impact of the 100,000,000 share increase in the 2024 Omnibus Incentive Plan on potential future dilution.
- Confirm the effective date and specific procedures for the new written consent mechanism in the amended Certificate of Incorporation.
- Review the full text of the Plan Amendment (Exhibit 10.1) and Certificate of Amendment (Exhibit 3.1) attached to the filing for detailed terms.
- Note the significant number of broker non-votes (533,520) on director elections and the plan/charter amendments, indicating shares held in street name where brokers lacked discretionary voting power.